149 related articles for article (PubMed ID: 19342835)
1. Patients at high risk of cerebrovascular disease: the REACH study.
Mostaza JM; Martín-Jadraque R; Vicente I; San Martin MA; Lahoz C
Cerebrovasc Dis; 2009; 27 Suppl 1():77-81. PubMed ID: 19342835
[TBL] [Abstract][Full Text] [Related]
2. Low rates of preventive practices in patients with peripheral vascular disease.
Anand SS; Kundi A; Eikelboom J; Yusuf S
Can J Cardiol; 1999 Nov; 15(11):1259-63. PubMed ID: 10579741
[TBL] [Abstract][Full Text] [Related]
3. Type 3 phosphodiesterase inhibitors may be protective against cerebrovascular events in patients with claudication.
Stone WM; Demaerschalk BM; Fowl RJ; Money SR
J Stroke Cerebrovasc Dis; 2008; 17(3):129-33. PubMed ID: 18436153
[TBL] [Abstract][Full Text] [Related]
4. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
[TBL] [Abstract][Full Text] [Related]
5. Coronary, peripheral and cerebrovascular disease: a complex relationship.
Shah AM; Banerjee T; Mukherjee D
J Indian Med Assoc; 2010 May; 108(5):292-4, 296. PubMed ID: 21121404
[No Abstract] [Full Text] [Related]
6. [Cerebrovascular mortality in Portugal: are we overemphasizing hypertension and neglecting atrial fibrillation?].
Providência R; Gonçalves L; Ferreira MJ
Rev Port Cardiol; 2013 Nov; 32(11):905-13. PubMed ID: 24246719
[TBL] [Abstract][Full Text] [Related]
7. Etiopathogenesis of transient ischemic attacks and minor ischemic strokes: a community-based study in Segovia, Spain.
Sempere AP; Duarte J; Cabezas C; Clavería LE
Stroke; 1998 Jan; 29(1):40-5. PubMed ID: 9445326
[TBL] [Abstract][Full Text] [Related]
8. Prevention of recurrent stroke.
Leonberg SC; Elliott FA
Stroke; 1981; 12(6):731-5. PubMed ID: 7303062
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of implementation of established recommended secondary prevention measures in patients with PAOD.
Flu HC; Tamsma JT; Lindeman JH; Hamming JF; Lardenoye JH
Eur J Vasc Endovasc Surg; 2010 Jan; 39(1):70-86. PubMed ID: 19910222
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular disease, associated risk factors and antithrombotic therapy in a population screening cohort: Insights from the Belgian Heart Rhythm Week programme.
Proietti M; Mairesse GH; Goethals P; Scavee C; Vijgen J; Blankoff I; Vandekerckhove Y; Lip GY;
Eur J Prev Cardiol; 2017 Feb; 24(3):328-334. PubMed ID: 27909151
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
[TBL] [Abstract][Full Text] [Related]
12. Lessons from the REACH Registry in Europe.
Valentijn TM; Stolker RJ
Curr Vasc Pharmacol; 2012 Nov; 10(6):725-7. PubMed ID: 23259566
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.
Arch Intern Med; 1994 Jul; 154(13):1449-57. PubMed ID: 8018000
[TBL] [Abstract][Full Text] [Related]
14. Stroke risk management: changes in mainstream practice.
Kalra L; Perez I; Melbourn A
Stroke; 1998 Jan; 29(1):53-7. PubMed ID: 9445328
[TBL] [Abstract][Full Text] [Related]
15. Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels. HIT Investigators. Department of Veterans Affairs HDL Intervention Trial.
Papademetriou V; Narayan P; Rubins H; Collins D; Robins S
Am Heart J; 1998 Oct; 136(4 Pt 1):734-40. PubMed ID: 9778079
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of the CHADS
Tabata N; Yamamoto E; Hokimoto S; Yamashita T; Sueta D; Takashio S; Arima Y; Izumiya Y; Kojima S; Kaikita K; Matsui K; Fujimoto K; Sakamoto K; Shimomura H; Tsunoda R; Hirose T; Nakamura N; Sakaino N; Nakamura S; Yamamoto N; Matsumura T; Kajiwara I; Koide S; Sakamoto T; Nakao K; Oshima S; Tsujita K;
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862941
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular morbidity and mortality in peripheral arterial disease.
Eberhardt RT; Coffman JD
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):209-17. PubMed ID: 15379611
[TBL] [Abstract][Full Text] [Related]
18. Current status of risk factors for stroke.
Wolf PA; Kannel WB; Verter J
Neurol Clin; 1983 Feb; 1(1):317-43. PubMed ID: 6680164
[TBL] [Abstract][Full Text] [Related]
19. Stroke risk factors and stroke prevention.
Elkind MS; Sacco RL
Semin Neurol; 1998; 18(4):429-40. PubMed ID: 9932614
[TBL] [Abstract][Full Text] [Related]
20. Role of ACE inhibitors in hypertension complicated by vascular disease.
McInnes GT
Br Heart J; 1994 Sep; 72(3 Suppl):S33-7. PubMed ID: 7946801
[No Abstract] [Full Text] [Related]
[Next] [New Search]
